GHK-Cu is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
The half-life of GHK-Cu is approximately 2-4 hours. This means dosing once daily is typical to maintain stable levels. The half-life directly affects how long GHK-Cu remains active and influences optimal injection timing.
What Is the Half-Life of GHK-Cu?
The half-life of GHK-Cu is approximately 2-4 hours. This is the time it takes for blood concentration to drop by 50% after administration.
Understanding half-life is essential for designing effective dosing protocols — it determines how often you need to administer GHK-Cu to maintain therapeutic blood levels.
What Does GHK-Cu's Half-Life Mean for Dosing?
With a half-life of approximately 2-4 hours, GHK-Cu requires dosing once daily to maintain stable levels. The standard dosage of 1-3 mg (injectable), topical formulations vary via subcutaneous injection or topical application accounts for this pharmacokinetic profile.
After approximately 4-5 half-lives, GHK-Cu reaches steady-state concentration — the point where the amount being absorbed equals the amount being eliminated. For GHK-Cu, this occurs within the first few days of consistent dosing.
When Is the Best Time to Inject GHK-Cu?
Optimal timing depends on your research goals. A half-life of approximately 2-4 hours means peak blood levels occur shortly after injection and decline predictably.
Common timing approaches: morning injection for daytime activity, pre-bed injection for overnight effects, or split dosing (once daily) for more stable levels throughout the day.
How Does GHK-Cu's Half-Life Compare to Similar Peptides?
GHK-Cu is a Tripeptide-copper complex. Its half-life of approximately 2-4 hours positions it with a shorter duration of action compared to some alternatives in this class.
Shorter half-lives require more frequent dosing but allow for more precise control. Longer half-lives are more convenient but carry risk of accumulation.
Calculate Your GHK-Cu Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for GHK-Cu.
Open Calculator →Bottom Line: GHK-Cu Half-Life and Dosing
GHK-Cu has a half-life of approximately 2-4 hours, supporting the standard protocol of 1-3 mg (injectable), topical formulations vary dosed once daily over 4-12 weeks.
Read our GHK-Cu dosage guide for complete protocol details.
Complete Guide
GHK-Cu: The Copper Peptide Research Roundup
Related Reading
- GHK-Cu Dosage Guide
- GHK-Cu Benefits
- GHK-Cu Side Effects
- GHK-Cu Stacking Guide
- GHK-Cu Cycle Guide
- GHK-Cu Research
Research-Grade Sourcing
If you're going to research GHK-Cu, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is GHK-Cu?
GHK-Cu (GHK-Cu (Copper Peptide)) is a Tripeptide-copper complex. Naturally occurring peptide found in human plasma, saliva, and urine; levels decline significantly with age from 200 ng/mL at age 20 to 80 ng/mL by age 60. It is researched for skin rejuvenation, wound healing, anti-aging, hair growth, collagen production, anti-inflammatory effects.
What is the recommended GHK-Cu dosage?
Common dosages: 1-3 mg (injectable), topical formulations vary administered once daily via subcutaneous injection or topical application. Cycle length: 4-12 weeks. Half-life: approximately 2-4 hours. Use our peptide calculator for exact reconstitution math.
What are the side effects of GHK-Cu?
Well-tolerated in research and cosmetic use. Mild injection site reactions possible. Topical use may cause temporary skin redness in sensitive individuals. No systemic toxicity reported.
Is GHK-Cu safe?
GHK-Cu has shown a favorable safety profile in research. Not regulated as a drug. Available as a research chemical and widely used in cosmetic formulations. One of the most accessible peptides legally. All research should follow appropriate safety protocols.